Last reviewed · How we verify

NCT04242316

Effects of Mirror Therapy and Bilateral Arm Training on Hemiparetic Upper Extremity in Patients With Chronic Stroke

Completed NA Last updated 27 January 2020
What this trial tests

NA trial testing Mirror Therapy in Stroke in 101 participants. Completed in 1 January 2019.

Timeline
1 January 2014
Primary endpoint
1 January 2017
1 January 2019

Quick facts

Lead sponsorThe Hong Kong Polytechnic University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment101
Start date1 January 2014
Primary completion1 January 2017
Estimated completion1 January 2019

Drugs / interventions tested

Conditions studied

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 18 to 80, any sex, with Stroke or Hemiplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study included (1) to compare the effectiveness of mirror therapy (MT) and bimanual arm training (BAT) in improving motor and functional performance of hemiplegic upper extremity for adults with chronic stroke; (2) to examine whether recruitment of the mirror neurons, as reflected in mu rhythm suppression, mediates recognition of the mirror illusion in pre/post MT, as compared to BAT without a mirror in clients with chronic stroke, as compared to healthy participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mirror Therapy

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04242316.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing